Cargando...

Intravenous Immunoglobulins: Evolution of Commercial IVIG Preparations

Since its first use in 1952, human immunoglobulin has been used to treat people who have inherited antibody deficiencies. This article summarizes IVIG clinical development in primary immunodeficient patients and manufacturing improvements introduced over time. Manufacturing improvements include puri...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Immunol Allergy Clin North Am
Autor Principal: Hooper, John A.
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier Inc. 2008
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7135658/
https://ncbi.nlm.nih.gov/pubmed/18940573
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.iac.2008.06.002
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!